Why People With Type 1 Diabetes May Face Higher Rates of Chronic Sinus Disease

When you live with Type 1 diabetes, your immune system affects more than just blood sugar control. New research reveals that Type 1 diabetes shares inflammatory pathways with chronic rhinosinusitis (CRS)—a long-lasting condition that affects the sinuses and nasal passages. A comprehensive review of 24 studies published in the International Forum of Allergy & Rhinology examined how various autoimmune conditions, including Type 1 diabetes, relate to chronic sinus disease.

The researchers used genetic studies to identify causal relationships between Type 1 diabetes and CRS. These relationships are mediated by specific inflammatory molecules in the body—chemical messengers that drive inflammation. Understanding these shared pathways helps explain why people with autoimmune diseases may face higher risks of sinus problems.

The review found varying levels of association between different autoimmune conditions and chronic rhinosinusitis. Rheumatoid arthritis showed the most consistent association, followed by Sjögren's syndrome (an autoimmune condition affecting moisture-producing glands). Type 1 diabetes, along with systemic lupus erythematosus (SLE), ankylosing spondylitis, and celiac disease, demonstrated moderate but significant associations with CRS.

One distinct finding involved IgG4-related disease, which created a specific type of CRS phenotype affecting the sinuses in 32% to 59% of cases. This variation highlights that different autoimmune conditions may affect sinus health in different ways.

The research revealed that people with autoimmune diseases who also have chronic rhinosinusitis experience worse outcomes than those with CRS alone. These individuals reported lower quality of life and experienced more frequent acute sinus infections. For people already managing Type 1 diabetes, these additional sinus complications can add another layer of health management.

Interestingly, the type of CRS mattered: chronic rhinosinusitis without nasal polyps showed stronger associations with autoimmune diseases than CRS with polyps. This suggests that different forms of sinus disease may have different underlying causes, which could eventually lead to more targeted treatment approaches.

While this research establishes important connections between Type 1 diabetes and chronic rhinosinusitis, it does not change current diabetes management. However, it does highlight the importance of paying attention to persistent sinus symptoms. If you have Type 1 diabetes and experience chronic sinus congestion, frequent infections, or ongoing nasal symptoms, discussing these concerns with your healthcare team is worthwhile.

The inflammatory mechanisms identified in this review—involving molecules like IL-10, CXCL10, and CD6—represent areas where future treatments might be developed. For now, this research underscores that autoimmune diseases affect multiple body systems, and a whole-person approach to health care remains essential.

Source: International forum of allergy & rhinology. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.